Document is current
Any future updates will be listed below
-
Authors
Takeda, Chikashi https://orcid.org/0000-0002-0903-0201
Yamashita, Yugo
Masui, Kenichi
Sugimura, Motoi
Fujita, Satoru
Kakinohana, Manabu
Kita, Takashi
Edanaga, Mitsutaka
Sato, Tetsufumi
Fujimura, Naoyuki
Yamamoto, Naoto
Ikeda, Masataka
Kawaguchi, Ryuji
Neki, Reiko
,
-
Funding
Funding for this research was provided by:
Japanese Society of Intensive Care Medicine
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 25 November 2025
First Online: 9 December 2025
Declarations
:
: Yugo Yamashita has received lecture fees from Daiichi-Sankyo, Pfizer, Bristol-Myers Squibb, and Bayer Healthcare. Kenichi Masui received payments for delivering domestic lectures from Sandoz K.K. (Tokyo, Japan), Terumo Corporation (Tokyo, Japan), Mundipharma K.K. (Tokyo, Japan), Masimo Japan Corporation (Tokyo, Japan), Covidien Japan Inc. (Tokyo, Japan), Pfizer Japan Inc. (Tokyo, Japan), and MSD K.K. (Tokyo, Japan); and consultancy from Mundipharma K.K. (Tokyo, Japan) and Terumo Corporation (Tokyo, Japan). The authors declare no conflict of interest.
